Price $125.34 |
Market Cap
27.02B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
81.3
|
P/B
2.62
|
P/S
5.86
|
Dividend %
-
|
|
P/CF
24.6
|
P/FCF
69.2
|
Op. Cash Flow
556.6K
|
FCF
1.6
|
|
Op. Margin
12.00%
|
Net Margin
9.60%
|
ROE
4.50%
|
ROI
0.40%
|
|
ROA
3.00%
|
EPS Growth
-20.80%
|
Current Ratio
2.9
|
Debt/Equity
31.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Celexus Inc (CXUS) | $1.61 | - | - | 5.2M | Strong Buy |
| PDL BioPharma Inc (PDLI) | $2.95 | - | - | 355.9M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.29 | - | - | 10.6M | Strong Buy |
| ImmuCell Corporation (ICCC) | $6.54 | - | - | 44.5M | Strong Buy |
| DURECT Corporation (DRRX) | $0.68 | - | - | 86M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
